Thrombosis
Thrombosis
Advertisement
Patrick DalyVTE | November 8, 2023
Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on.
Read More
Patrick DalyThrombosis | November 8, 2023
Splenomegaly and myeloproliferative disorders increased risk for porto-spleno-mesenteric venous thrombosis after splenectomy.
Patrick DalyThrombosis | October 25, 2023
Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths.
Patrick DalyHematology | October 16, 2023
Subclinical leaflet thrombosis appears more common after TAVR versus SAVR, but was not associated with increased stroke risk.
Patrick DalyAtrial Fibrillation | February 27, 2023
Researchers compared the safety and efficacy of two direct oral anticoagulants (DOACs), apixaban and rivaroxaban, ...
Amit Goyal, MDCardioNerds | January 30, 2023
Results from the OCEAN-TAVI registry indicate that a non-antithrombotic strategy may be reasonable following ...
Hady Lichaa, MDPractice Tips With Dr. Lichaa | January 25, 2023
In the second half of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, spoke with ...
Hady Lichaa, MDPractice Tips With Dr. Lichaa | January 24, 2023
In part one of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, sits down with ...
CardioNerdsCardioNerds | November 2, 2022
It’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of ...
Rob DillardThrombosis | August 22, 2022
DocWire News recently spoke with Dan Bloomfield, MD, FACC, FAHA, Chief Medical Officer of Anthos Therapeutics. Dr. ...
Patrick DalyThrombosis | July 22, 2022
According to a recent study, the use of short-term, low-dose dabigatran could significantly reduce the risk of bleeding ...
Amit Goyal, MDCardioNerds | July 19, 2022
The clinical impact of subclinical leaflet thrombosis following transcatheter aortic valve replacement (TAVR) is ...
Patrick DalyKidney Transplantation | July 18, 2022
Researchers assessed the UK experience of kidney transplantations from deceased donors who had vaccine-induced immune ...
Patrick DalyAtherosclerotic Disease | May 19, 2022
Researchers reported that "assessing total arterial and venous thrombotic events, not just first events, provides more ...
Patrick DalyITP | May 18, 2022
In a study in Research and Practice in Thrombosis and Haemostasis, researchers examined changes in clinical and platelet ...
Patrick DalyAtrial Fibrillation | May 9, 2022
Researchers explored the optimal duration of triple antithrombotic therapy (TAT) in patients who have atrial ...
Patrick DalyAtrial Fibrillation | April 25, 2022
Therapies that can reduce risk of thrombosis without increasing bleeding complications are needed to improve stroke ...
Patrick DalyVTE | April 15, 2022
Apixaban has been shown to be effective for preventing venous thromboembolism (VTE) in patients with cancer, but is ...
Patrick DalyAtherosclerotic Disease | February 16, 2022
In the VOYAGER PAD study, published in the Journal of Thrombosis and Haemostasis, researchers assessed symptom burden in ...
Rob DillardCardiology | February 3, 2022
Recently, the CHEETAH study (initiated in 2019), the first large study to demonstrate the safety ...
Advertisement
Advertisement
Advertisement
Latest News

December 1, 2023